HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of congenital protein C deficiency with pulmonary thromboembolism].

Abstract
A 47-year-old woman, with a history of recurrent venous thrombosis in her lower limbs (1988 and June, 1992), was admitted because of pulmonary thromboembolism in the right middle lung lobe. She was given anti-coagulant therapy with warfarin. The consolidation in the right middle lobe disappeared within two months. Hematological examinations concerning the coagulation and fibrinolytic system showed a significant decrease in both the serum concentration and the activity of protein C, a vitamin K-dependent hepatic protein which acts as an anticoagulant by shutting off fibrin formation and stimulating fibrinolysis. Since a sister of the patient also has a history of venous thrombosis, several members of her family were tested for protein C deficiency. The familial study revealed that her sister and mother had both a decreased concentration and depressed activity of protein C, indicating that this is a case of congenital protein C deficiency. Warfarin therapy has been continued to reduce the prothrombin time to 70% of the normal control level, resulting in no further episodes of thrombosis.
AuthorsK Takeda, H Kumagai, S Hayashi, Y Tanio, I Kawase, T Kishimoto, M Fujiwara
JournalNihon Kyobu Shikkan Gakkai zasshi (Nihon Kyobu Shikkan Gakkai Zasshi) Vol. 32 Issue 5 Pg. 497-501 (May 1994) ISSN: 0301-1542 [Print] Japan
PMID8084108 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Protein C
  • Warfarin
Topics
  • Female
  • Humans
  • Middle Aged
  • Protein C (genetics)
  • Protein C Deficiency
  • Prothrombin Time
  • Pulmonary Embolism (drug therapy, etiology)
  • Recurrence
  • Thrombophlebitis (drug therapy, etiology)
  • Warfarin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: